Literature DB >> 31907454

A bipartite structural organization defines the SERINC family of HIV-1 restriction factors.

Annachiara Rosa1, Cinzia Bertelli2, Valerie E Pye1, Weston B Struwe3, Sarah L Maslen4, Robin Corey5, Idlir Liko3, Mark Hassall6, Giada Mattiuzzo6, Allison Ballandras-Colas1, Andrea Nans7, Yasuhiro Takeuchi6,8, Phillip J Stansfeld5,9, J Mark Skehel4, Carol V Robinson3, Massimo Pizzato10, Peter Cherepanov11,12.   

Abstract

The human integral membrane protein SERINC5 potently restricts HIV-1 infectivity and sensitizes the virus to antibody-mediated neutralization. Here, using cryo-EM, we determine the structures of human SERINC5 and its orthologue from Drosophila melanogaster at subnanometer and near-atomic resolution, respectively. The structures reveal a novel fold comprised of ten transmembrane helices organized into two subdomains and bisected by a long diagonal helix. A lipid binding groove and clusters of conserved residues highlight potential functional sites. A structure-based mutagenesis scan identified surface-exposed regions and the interface between the subdomains of SERINC5 as critical for HIV-1-restriction activity. The same regions are also important for viral sensitization to neutralizing antibodies, directly linking the antiviral activity of SERINC5 with remodeling of the HIV-1 envelope glycoprotein.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31907454      PMCID: PMC6956856          DOI: 10.1038/s41594-019-0357-0

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  55 in total

1.  SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.

Authors:  Chetan Sood; Mariana Marin; Ajit Chande; Massimo Pizzato; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

2.  Disruption of Serinc1, which facilitates serine-derived lipid synthesis, fails to alter macrophage function, lymphocyte proliferation or autoimmune disease susceptibility.

Authors:  Edward P F Chu; Colleen M Elso; Abigail H Pollock; May A Alsayb; Leanne Mackin; Helen E Thomas; Thomas W H Kay; Pablo A Silveira; Ashley S Mansell; Katharina Gaus; Thomas C Brodnicki
Journal:  Mol Immunol       Date:  2016-12-19       Impact factor: 4.407

3.  The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.

Authors:  Birthe Trautz; Hannah Wiedemann; Christian Lüchtenborg; Virginia Pierini; Jan Kranich; Bärbel Glass; Hans-Georg Kräusslich; Thomas Brocker; Massimo Pizzato; Alessia Ruggieri; Britta Brügger; Oliver T Fackler
Journal:  J Biol Chem       Date:  2017-06-28       Impact factor: 5.157

4.  Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5.

Authors:  Bianca Schulte; Anastasia Selyutina; Silvana Opp; Alon Herschhorn; Joseph G Sodroski; Massimo Pizzato; Felipe Diaz-Griffero
Journal:  Virology       Date:  2017-12-18       Impact factor: 3.616

5.  Serinc, an activity-regulated protein family, incorporates serine into membrane lipid synthesis.

Authors:  Madoka Inuzuka; Minako Hayakawa; Tatsuya Ingi
Journal:  J Biol Chem       Date:  2005-08-24       Impact factor: 5.157

6.  S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.

Authors:  Ajit Chande; Emilia Cristiana Cuccurullo; Annachiara Rosa; Serena Ziglio; Susan Carpenter; Massimo Pizzato
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-01       Impact factor: 11.205

7.  The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5.

Authors:  Iqbal Ahmad; Sunan Li; Rongrong Li; Qingqing Chai; Lixin Zhang; Bin Wang; Changqing Yu; Yong-Hui Zheng
Journal:  J Biol Chem       Date:  2019-03-12       Impact factor: 5.157

Review 8.  Evolutionary conflicts between viruses and restriction factors shape immunity.

Authors:  Nisha K Duggal; Michael Emerman
Journal:  Nat Rev Immunol       Date:  2012-09-14       Impact factor: 53.106

9.  HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.

Authors:  Annachiara Rosa; Ajit Chande; Serena Ziglio; Veronica De Sanctis; Roberto Bertorelli; Shih Lin Goh; Sean M McCauley; Anetta Nowosielska; Stylianos E Antonarakis; Jeremy Luban; Federico Andrea Santoni; Massimo Pizzato
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

10.  SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.

Authors:  Yoshiko Usami; Yuanfei Wu; Heinrich G Göttlinger
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

View more
  28 in total

1.  Structure and function at the lipid-protein interface of a pentameric ligand-gated ion channel.

Authors:  Pramod Kumar; Gisela D Cymes; Claudio Grosman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

2.  Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection.

Authors:  Saina Beitari; Qinghua Pan; Andrés Finzi; Chen Liang
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

3.  Nef homodimers down-regulate SERINC5 by AP-2-mediated endocytosis to promote HIV-1 infectivity.

Authors:  Ryan P Staudt; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2020-09-01       Impact factor: 5.157

4.  SERINC5 Inhibits HIV-1 Infectivity by Altering the Conformation of gp120 on HIV-1 Particles.

Authors:  Austin Featherstone; Christopher Aiken
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

5.  HIV-cell membrane fusion intermediates are restricted by Serincs as revealed by cryo-electron and TIRF microscopy.

Authors:  Amanda E Ward; Volker Kiessling; Owen Pornillos; Judith M White; Barbie K Ganser-Pornillos; Lukas K Tamm
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

6.  An Amino Acid Polymorphism within the HIV-1 Nef Dileucine Motif Functionally Uncouples Cell Surface CD4 and SERINC5 Downregulation.

Authors:  Mitchell J Mumby; Aaron L Johnson; Steven M Trothen; Cassandra R Edgar; Richard Gibson; Peter B Stathopulos; Eric J Arts; Jimmy D Dikeakos
Journal:  J Virol       Date:  2021-07-26       Impact factor: 5.103

7.  Selective Disruption of SERINC5 Antagonism by Nef Impairs SIV Replication in Primary CD4+ T Cells.

Authors:  Sanath Kumar Janaka; Alexandra V Palumbo; Aidin Tavakoli-Tameh; David T Evans
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

8.  HIV envelope tail truncation confers resistance to SERINC5 restriction.

Authors:  Tafhima Haider; Xenia Snetkov; Clare Jolly
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 12.779

9.  Super-Resolution Fluorescence Imaging Reveals That Serine Incorporator Protein 5 Inhibits Human Immunodeficiency Virus Fusion by Disrupting Envelope Glycoprotein Clusters.

Authors:  Yen-Cheng Chen; Chetan Sood; Mariana Marin; Jesse Aaron; Enrico Gratton; Khalid Salaita; Gregory B Melikyan
Journal:  ACS Nano       Date:  2020-06-01       Impact factor: 15.881

10.  Downregulation of SERINC5 expression in buffy coats of HIV-1-infected patients with detectable or undetectable viral load.

Authors:  Elsie Guadalupe Hernández-López; Gracia Viviana González-Enríquez; Blanca Miriam Torres-Mendoza; Jhonathan Cárdenas-Bedoya; Martha Escoto-Delgadillo; Eduardo Vázquez-Valls; Alma Minerva Pérez-Ríos; David Alejandro Carbajal-Uribe; Ana Rosa Rincón-Sánchez
Journal:  Mol Biol Rep       Date:  2021-06-07       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.